Market Capitalization of Concord Drugs (CONCORD)
As of July 6, 2026, Concord Drugs (CONCORD) market capitalisation is ₹98.83 Cr ($10.98M), with 1.31 Cr shares outstanding at a current price of ₹75.40 on BSE, ranking 3144 out of 5363 companies by market cap in our screener. Concord Drugs operates in the Healthcare sector and is classified as a Small Cap stock. View CONCORD price range for the annual high/low range and current price position.
Market Cap History of Concord Drugs (Last 10 Years)
CONCORD market capitalisation from year-end BSE closing prices over the last 10 years. For live price, earnings and the complete company profile, see Concord Drugs share price today.
End of Year Market Cap History — Concord Drugs
CONCORD year-end market cap in INR and USD with closing share price and annual change — BSE closing prices. Compare with CONCORD fair value to assess whether the stock is under or overvalued.
| Year | Market Cap | Share Price | Exchange | Change |
|---|---|---|---|---|
| 2026 |
₹98.83 Cr
$10.98M USD
|
₹75.40 | BSE | -8.58% |
| 2025 |
₹108.11 Cr
$12.01M USD
|
₹82.48 | BSE | +118.78% |
| 2024 |
₹49.41 Cr
$5.49M USD
|
₹37.70 | BSE | -36.87% |
| 2023 |
₹78.28 Cr
$8.70M USD
|
₹59.72 | BSE | +83.47% |
| 2022 |
₹42.66 Cr
$4.74M USD
|
₹32.55 | BSE | +1.24% |
| 2021 |
₹42.14 Cr
$4.68M USD
|
₹32.15 | BSE | +40.39% |
| 2020 |
₹30.02 Cr
$3.34M USD
|
₹22.90 | BSE | +52.67% |
| 2019 |
₹19.66 Cr
$2.18M USD
|
₹15.00 | BSE | -33.63% |
| 2018 |
₹29.62 Cr
$3.29M USD
|
₹22.60 | BSE | -29.37% |
| 2017 |
₹41.94 Cr
$4.66M USD
|
₹32.00 | BSE | -34.69% |
| 2016 |
₹64.23 Cr
$7.14M USD
|
₹49.00 | BSE | -17.72% |
| 2015 |
₹78.05 Cr
$8.67M USD
|
₹59.55 | BSE | - |